West Nile Virus :: Second human West Nile virus case identified in Illinois
The Illinois Department of Public Health has confirmed through laboratory tests the second human West Nile virus case in Illinois for 2007.
The Illinois Department of Public Health has confirmed through laboratory tests the second human West Nile virus case in Illinois for 2007.
Adolescents from low-income families are much more likely to suffer from migraine headaches than teens from wealthier households, according to researchers at the Albert Einstein College of Medicine of Yeshiva University.
Acute mountain sickness affects almost half of those ascending to heights over 3,000 meters and may lead to life-threatening complications such as pulmonary or cerebral edema. A new study appearing in Journal of Travel Medicine details a prospective on-site study in the Himalayas between July and October 2004 in which the knowledge and practices concerning AMS were examined amongst trekkers.
Saxagliptin, an inhibitor of dipeptidyl-peptidase-4 (DPP-4) in development by Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN), in combination with metformin, exhibited a statistically significant improvement in glycemic control in subjects with Type 2 diabetes compared to metformin alone through 24 weeks of treatment.
Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced today that it has received an approvable letter from the U.S. Food and Drug Administration (FDA) for INTUNIV (guanfacine) extended release tablets (previously referred to as SPD503), a nonstimulant selective alpha-2A-receptor agonist that has been studied in children and adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD).
Keeping cool on hot, humid summer days is good advice for more reasons than sheer comfort. It’s vital for good health – even staying alive. That’s the message from the Pennsylvania Medical Society, warning young and old alike that heat stroke is a deadly illness to be avoided at all costs – even if it means sacrificing a day at the beach.
Results of the Option (TOcilizumab Pivotal Trial in Methotrexate Inadequate respONders) trial, the first multinational Phase III study outside of Japan, showed that patients treated with Actemra (either 4mg/kg or 8mg/kg) plus methotrexate achieved a significant and clinically important improvement in the signs and symptoms of moderate to severe rheumatoid arthritis (RA) compared to patients treated with placebo and methotrexate, a current standard of care.
Reported cases of Lyme disease have more than doubled since 1991, when Lyme became a nationally notifiable disease, according to a report by the Centers for Disease Control and Prevention (CDC). The report also said 93 percent of reported cases were concentrated in 10 states.
Sanofi-aventis announced that the U.S. Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee did not recommend approval of rimonabant (ZIMULTI(R)) to the US FDA for use in obese and overweight patients with associated risks factors.
Following the confirmation on 25 May 2007 by Health Authorities of the United Kingdom, of influenza A/H7N2 virus infection in four individuals (two in Wales and two in north-west England) exposed to infected poultry at smallholding, Corwen Farm, Conwy, Wales, the National Public Health Service (NPHS) for Wales is continuing with the investigation of the incident and with the implementation of public health measures.